Skip to main content
Supporting People With Alzheimer’s Disease Transitioning to Different Stages
Future of Personal Health
Blood Health
Infectious Diseases
Rare Diseases
More
Antibiotic Resistance
Breast Health
Cancer Care
Cardiovascular Health
Colorectal Health
Diabetes
Digestive Health and Diseases
Epilepsy
Healthy Aging Empowerment
Heart and Stroke
Infectious Diseases
Living With HIV & Aids
Lung Health
Men's Mental Health
Health Equity
Opioid Awareness
Oral Health
Ovarian Cancer Awareness
Prostate and Urological Health
Senior Health
Skin Health
Transplants
Substance Misuse and Suicide Prevention
Vaccine Awareness
Vision Care
Antibiotic Resistance
Breast Health
Cancer Care
Cardiovascular Health
Colorectal Health
Diabetes
Digestive Health and Diseases
Epilepsy
Healthy Aging Empowerment
Heart and Stroke
Infectious Diseases
Living With HIV & Aids
Lung Health
Men's Mental Health
Health Equity
Opioid Awareness
Oral Health
Ovarian Cancer Awareness
Prostate and Urological Health
Senior Health
Skin Health
Transplants
Substance Misuse and Suicide Prevention
Vaccine Awareness
Vision Care
Fighting Alzheimer's
Why Creating a Positive Care Culture Is Key To Slowing Alzheimer’s
Fighting Alzheimer's
5 Ways to Lower Your Risk for Alzheimer’s Disease
Fighting Alzheimer's
How Caregivers Can Find Safety Nets in a Sea of Change
Fighting Alzheimer's
Steps To Reduce Caregiver Stress
Fighting Alzheimer's
Supporting People With Alzheimer’s Disease Transitioning to Different Stages
Fighting Alzheimer's
Aphasia and the Role of the Caregiver
Sponsored
Eisai Is Pioneering Alzheimer’s Research and Working to Improve the Experience of People Living With the Disease
“Never giving up” is the message Eisai Co., Ltd., emphasizes when it comes to the company’s four decades of Alzheimer’s research. The global pharmaceutical company headquartered in Tokyo, with its U.S. headquarters in New Jersey, is focused on developing innovative solutions for people and families living with Alzheimer’s disease (AD) and other neurodegenerative diseases.
